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There is great interest in the therapeutic potential of cell-based therapies, referred to as regenerative medicine, which generally encompass
the use of embryonic stem cells and reprogrammed adult cells with embryonic stem cells-like properties, called induced pluripotent stem
cells. However, key issues such as optimal strategies for cellular reprogramming and directed differentiation to ensure efficacy and safety
of regenerative therapy have not been resolved. In this review, Ao et al. discuss these challenges and the innovative uses of synthetic chem-
icals to tackle them. The emerging study of regenerative chemical biology has far-reaching impact on the future of regenerative medicine.
Engineering Improved Selectivity towards Malarial Parasites
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A number of structurally less complex and more stable analogs of pactamycin have been generated by Lu et al. from genetically engineered
strains of Streptomyces pactum. The compounds show potent antimalarial activity but, in contrast to pactamycin, have significantly reduced
antibacterial activity and cytotoxicity against mammalian cells. The results suggest that distinct ribosomal binding selectivity or new mech-
anism(s) of actionmay be involved in their plasmodial growth inhibition, whichmay lead to a newdirection in the discovery and development of
drugs against malaria and other life-threatening protozoal infections.
Resistant Smoothened Conquered
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Small-molecule antagonists for Smoothened (Smo) have been developed and achieved promising preclinical efficacy in cancers. However,
tumor relapse was quickly developed due to a drug-resistant mutation on SMO. Here Tao et al. report two Smo antagonists that bind to
distinct sites and inhibit both wild-type and mutant Smo. These findings provide an insight of the ligand binding sites of Smo and a basis
for the development of potential therapeutics for tumors with drug-resistant Smo mutations.
Supramolecular Templating in Kirromycin Biosynthesis
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In the biosynthesis of complex polyketides, acyltransferase domains (ATs) are key determinants of structural diversity. Their specificity and
position in polyketide synthases (PKSs) usually controls the location and structure of building blocks in polyketides. Many bioactive polyke-
tides, however, are generated by trans-AT PKSs lacking internal AT domains. They were previously believed to employ mainly malonyl-
specific free-standing ATs. Here, Musiol et al. report a mechanism of structural diversification in which the trans-AT KirCII regiospecifically
incorporates the unusual extender unit ethylmalonyl-CoA in kirromycin polyketide biosynthesis.Rerouted to Mitochondria: Path to Cancer Defeat
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Chlorambucil is a clinically used leukemia drug that alkylates nuclear DNA. However, resistance
against the drug has been noted, limiting its effectiveness. Fonseca et al. investigated whether
redirecting chlorambucil from the nucleus to another cellular organelle that also contains DNA,
the mitochondria, would allow retention of activity and circumvention of resistance. This was
achieved using a peptide-based delivery system that is mitochondria specific. Indeed, evasion of
resistance and a significant increase in chlorambucil activity was observed in clinical samples.
This is the first successful delivery of an alkylating agent to mitochondria.
Multidrug Efflux Pump: Putting the Pieces Together
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Drug resistance presents an ever-increasing threat to public health and encompasses all major
microbial pathogens and antimicrobial drugs. Some pathogens have acquired resistance tomultipleantibiotics (multidrug resistance) and cause infections that are effectively untreatable. The high
multidrug resistance of Gram-negative pathogens is based on activities of multicomponent drug efflux
transporters. The study by Tikhonovsa et al. describes the reconstitution of the multidrug efflux pump
AcrAB-TolC that functions in the context of two membranes of E. coli. The kinetic analyses identified
a possible ‘‘bottleneck’’ in the assembly of the tripartite complex that could be targeted for develop-
ment of effective inhibitors of AcrAB-TolC assembly.
Cyclosporin A N-methylation
PAGE 464
The N-methylation of enzyme-bound intermediates is of general importance in the synthesis of many
peptide and depsipeptide antibiotics. The N-methylation of specific amide positions in the backbone
of cyclosporine A is critical for the efficient progression of peptide assembly to the mature undecapep-
tidyl stage. Velkov et al. establish that desmethylation of even a single amide appears to destabilize the
main conformation of cyclosporine A. Given the mechanistic similarities across nonribosomal peptide
synthetase (NRPS), these findings provide a biochemical model for N-methylation processes of NRPS
in general.Chemistry & Biology 18, April 22, 2011 ª2011 Elsevier Ltd All rights reserved v
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Cancer cells depend on different metabolic pathways from normal cells to support their malignant behavior. Mapping these metabolic path-
ways may uncover biochemical mechanisms that support tumorigenesis and identify new drug targets. The serine hydrolase KIAA1363 is
highly elevated in aggressive cancer cells, where it regulates ether lipid metabolism. Here, Chang et al. have created a potent, selective,
and in vivo-active inhibitor of KIAA1363. This compound, termed JW480, reduces ether lipids in cancer cells and impairs their migration, inva-
sion, and in vivo tumor growth. These studies support a protumorigenic function for KIAA1363 and report a versatile inhibitor for pharmaco-
logical characterization of this enzyme.Cross-Reactivity within Wnt/b-Catenin Signaling
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Verkaar et al. describe the screening of a small-molecule compound library for inhibitors of
Wnt/b-catenin signaling, an important pathway in embryonic development, adult stem cell
maintenance, and disease. The authors demonstrate that two clinically evaluated p38
MAPK inhibitors inhibit Wnt/b-catenin signaling by cross-reacting with casein kinase 1d and
3. These compounds may be repositioned as drugs for b-catenin-dependent disease, such
as coloncancer. In addition, casein kinase1dand 3are key regulators of themammaliancirca-
dian clock. Therefore, the inhibitors may potentially alleviate misalignment of the internal
clock, as experienced during jet lag, depression, and seasonal affective disorder.
Real-Time Imaging of Histones
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Histone acetylation is one important epigenetic mark whose information is read by bromodo-
main-containing proteins.Modulation of histone acetylation has also emerged as a promising
drug-target for anticancer therapy. In this study, Ito et al. developed a novel probe, Histac-
K12, that enables visualization of histone H4K12 acetylation in living cells. Using this probe,the authors could monitor changes in histone acetylation in vivo upon treatment with various histone deacetylase inhibitors and observe the
ability of a compound to inhibit the bromodomain binding to acetylated H4K12. Thus, Histac-K12 is useful for spatiotemporal analysis of
histone H4K12 acetylation in living cells and anticancer drug development.
Linking Chemistry and Genetics Cyanobactin Family
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Cyanobactins comprise one of themajor ribosomal peptide natural product families and arewidespread in cyanobacteria. Donia and Schmidt
developed and applied a phylogenetic model to understand the gene chemistry relationship in this family and to discover new pathways and
compounds. A tyrosine O-prenylating gene cluster and natural products from Spirulina health supplements are described.
Rationally Designing Catalysts for Natural Products
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Nature provides a great source of pharmaceuticals, but before a natural product potentially becomes a therapeutic agent, properties influ-
encing the pharmacological or pharmacokinetic qualities might have to be improved. By protein engineering, Ha¨rle et al. rationally designed
LanGT2, an O-glycosyltransferase, towards an enzyme able to catalyze sugar attachment by a C-glycosidic bond. The resulting structural
differencemight not influence the bioactivity but raises substantially the stability. The achievement in overcoming natural limitations by protein
engineeringmight document a general strategy in gaining further chemical diversity in the field of combinatorial biosynthesis and opens space
in creating valuable drugs.Preventing p53 from Causing Serious Damage
PAGE 531
Excessive activity of the master transcription regulator p53 activity during myocardial ischemia
causes irreversible cellular injury and cardiomyocyte death. In this study, Borah et al. discovered
a small molecule named ischemin that blocks p53 recruitment of transcriptional cofactor CBP,
thus preventing stress-induced apoptosis in ischemic cardiomyocytes.
Gliotoxin Biosynthesis in Aspergillus fumigatus
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Gliotoxin, a sulfur-contained molecule, is produced by the opportunistic human pathogen Asper-
gillus fumigatus and is known to play an important role in organism virulence. Amazingly, for over
70 years, the biological mechanism for the introduction of sulfur atoms into gliotoxin has remained
undiscovered. Here, Davis et al. demonstrate that an enzyme normally involved in detoxification
plays a key role in gliotoxin biosynthesis via the sulfurization of a gliotoxin biosynthetic intermediate
in A. fumigatus. The data also suggest that an acyl imine intermediate structure is present during
gliotoxin biosynthesis, and this has significant implications for biocatalysis using fungal enzymes.Chemistry & Biology 18, April 22, 2011 ª2011 Elsevier Ltd All rights reserved vii
